Lunit Inc. (KRX: 328130) and Summit Therapeutics Inc. announced a research agreement to evaluate the use of Lunit SCOPE IO, ...
GIM-621 is a preclinical-stage first-in-class oral small molecule immunotherapy with potential application across multiple ...
Harbour BioMed Secures China’s NMPA Approval for Batoclimab, Expanding Treatment Options for Myasthenia Gravis ...
Through its collaboration with OASES and partners across the healthcare ecosystem, Johnson & Johnson looks forward to: ...
Coreline Soft has received U.S. Food and Drug Administration (FDA) 510 (k) clearance for AVIEW Aorta Metrics, its AI-powered ...
Tairex, an AI healthcare technology company incubated by the Institute for AI Industry Research (AIR) at Tsinghua University, ...
Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovation-driven, global biopharma company, shared the first data from a ...
Nine markets, six questions, one page to pin above the desk. From Japan's 50,000-patient line to China's brand-new seven-year exclusivity, this is what a rare disease developer actually gets across ...
Therakos Development Limited, a global pioneer in immunomodulatory therapy delivered at the bedside through extracorporeal ...
NeuroXT Inc., a medical device manufacturer, announced that NEXT-Cue, its AI-based Software as a Medical Device (SaMD) ...
The new fiscal year is already two days into its own ledger. On 2 October 2026, FDA issued a letter to Hanlim Pharm in Yongin ...
Median 234 days from first CRO contact to site activation, range 74 to 657; median ethics approval 48 days, median governance ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results